MedTrace Logo

Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement

NCT01743313 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2023-10-18

No results posted yet for this study

Summary

Osteoarthritis patients undergoing primary hip and knee replacement are followed-up and changes in their glucose metabolism and other metabolic parameters (obesity, cholesterol levels) are examined. Persistent postoperative pain is examined as secondary outcome.

Conditions

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Coxa, Hospital for Joint Replacement

    lead OTHER

Principal Investigators

  • Esa Jämsen, MD, PhD · Coxa, Hospital for Joint Replacement

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-08-31
Completion
2017-06-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01743313 on ClinicalTrials.gov